Human Insulin Market by Drugs & Applications Human Insulin Market by Drugs & Applications | Page 23
LIST OF FIGURES
• FIGURE 27 INTERMEDIATE-ACTING DRUGS WILL CONTINUE TO DOMINATE
THE HUMAN INSULIN BIOLOGICS MARKET TILL 2020....................................................................................69
• FIGURE 28 NORTH AMERICA IS EXPECTED TO DOMINATE THE INTERMEDIATE-ACTING HUMAN
INSULIN BIOLOGICS MARKET DURING THE STUDY PERIOD...........................................................................71
• FIGURE 29 INSULIN ANALOGS & BIOSIMILAR DRUGS POISED TO GROW AT THE FASTEST RATE..................................75
• FIGURE 30 LANTUS EXPECTED TO HOLD THE LARGEST SHARE OF INSULIN ANALOGS
& BIOSIMILAR BRANDS MARKET TILL 2020....................................................................................................76
• FIGURE 31 ASIA-PACIFIC POISED TO BE THE FASTEST-GROWING MARKET FOR NOVORAPID DURING
THE FORECAST PERIOD....................................................................................................................................79
• FIGURE 32 HUMULIN IS POISED TO BE THE FASTEST-GROWING HUMAN INSULIN BIOLOGICS
BRANDS DURING 2015-2020............................................................................................................................82
• FIGURE 33 INSULIN PENS TO DOMINATE THE HUMAN INSULIN DELIVERY DEVICES MARKET DURING
THE FORECAST PERIOD (2015–2020)..............................................................................................................87
• FIGURE 34 APAC TO DOMINATE THE HUMAN INSULIN PEN NEEDLES MARKET BY 2020................................................91
• FIGURE 35 INDIA WILL HAVE THE HIGHEST DIABETES POPULATION BY 2030.................................................................97
• FIGURE 36 MARKET TRENDS: NORTH AMERICAN HUMAN INSULIN MARKET (2015-2020)...........................................102
• FIGURE 37 MARKET TRENDS: EUROPEAN HUMAN INSULIN MARKET (2015-2020).......................................................108
• FIGURE 38 ASIA-PACIFIC HUMAN INSULIN MARKET SNAPSHOT, 2015-2020................................................................117
• FIGURE 39 LEADING PLAYERS ADOPTED THE STRATEGY OF GEOGRAPHIC EXPANSIONS TO STRENG
THEN THEIR MARKET POSITIONING DURING 2012 TO 2015.........................................................................126
• FIGURE 40 GLOBAL HUMAN INSULIN MARKET SHARE, BY KEY PLAYER (2014)............................................................127
• FIGURE 41 GLOBAL HUMAN INSULIN DRUGS MARKET RANKING, BY KEY PLAYER (2014)...........................................129
• FIGURE 42 GLOBAL HUMAN INSULIN DELIVERY DEVICES MARKET RANKING, BY KEY PLAYER (2014).......................130
• FIGURE 43 CONTINUOUS GEOGRAPHIC EXPANSION IS STIMULATING MARKET COMPETITION
FOR CAPACITY BUILDING AMONG KEY PLAYERS.........................................................................................131
• FIGURE 44 GEOGRAPHIC REVENUE MIX OF THE TOP 5 MARKET PLAYERS* (2014).......................................................139
• FIGURE 45 LEADING COMPANIES ARE FOCUSING ON CAPACITY BUILDING TO STRENGTHEN
THEIR PRODUCT DEVE